Clinical trials or medical research studies offer a way for researchers to bring new therapies, medications, vaccines, and devices quicker to patients that need them. When a trial is held, rigorous protocols are always in place to protect the patient’s best outcome. Before phase one of any medical trial is brought to humans, they conduct thorough laboratory testing.
The IRB (Institutional Review Board) monitors all clinical trials to make certain that patients are protected. This independent committee of medical professionals and advocates keep track and make sure that federal regulations, ethics, and patients rights are upheld throughout the process.
How Clinical Trials Help
Disease states, illnesses and disorders are able to launch innovative and the most advanced treatments when clinical trials show positive outcomes. The average clinical trial allows advanced treatment options to be implemented in patient therapy protocols in an advantageous manner. Clinical trials also have helped countless individuals stave off disease states while under medical care during their researched disorder.
Francis S. Collins, M.D., Ph.D., Director of the National Institutes of Health, led the successful effort to complete the Human Genome Project, a complex multidisciplinary scientific enterprise to map and sequence human DNA. He spoke in early June to attendees of a 2011 conference, “Clinical Trials: New Challenges and Opportunities,” cosponsored by the National Library of Medicine, the Friends of the National Library of Medicine, and the American Association for the Advancement of Science. (1)
“Since its launch in 2000, Clinicaltrials.gov has grown in a breathtaking fashion. This free online database, created in response to a legislative mandate to help the public learn more about clinical trials, today contains descriptions, locations, and other vital information about more than 109,000 clinical trials.
Despite this great progress, many difficulties remain — difficulties that can delay or even thwart efforts to move scientific discoveries from the lab to the medical clinic. One of the biggest challenges is that very few Americans with common diseases are currently enrolled in clinical trials. For example, clinical trial participation stands at just 3 percent among U.S. adults with cancer.
If clinical trials are to be successful, it is critical that more people get involved. We need to spread the word about the value of participating in clinical trials. Signing up for a clinical trial may indeed benefit medical research and help future generations. But it is not strictly an altruistic endeavor. In many
instances, trial participants do gain personal advantages, such as improved disease outcomes or better health. And we should not be shy about telling that story.”
At Advanced Research for Health Improvement (ARHI), they believe that clinical studies will advance medicine and help people live better lives. With this mentality, they strive for greatness in each area of work that they do.
Are you interested in participating in a clinical trial? ARHI is currently accepting participants for studies in the areas of Heart Failure, Alzheimer’s Disease,
Pediatric Asthma, and Crohn’s Disease.
Call Today! 239-230-2021
1168 Goodlette-Frank Rd. N
Naples, FL 34102
(1) Collins, Francis, “The Importance of Clinical Trials,” NIH, Medline Plus: Summer 2011 Issue: Volume 6 Number 2 Page 2-3,